Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 300357.SZ

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Interest Coverage Ratio for the year ending December 31, 2023: 238.09

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Interest Coverage Ratio is 238.09 for the year ending December 31, 2023, a -73.39% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Interest Coverage Ratio for the year ending December 31, 2022 was 894.76, a -18.03% change year over year.
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Interest Coverage Ratio for the year ending December 31, 2021 was 1,091.60, a -66.24% change year over year.
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Interest Coverage Ratio for the year ending December 31, 2020 was 3,233.66, a -10.06% change year over year.
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Interest Coverage Ratio for the year ending December 31, 2019 was 3,595.33, a 15,755.68% change year over year.

Key data

Date	Interest Coverage Ratio	Debt to Equity Ratio	Interest Expense To Sales	Inventory Turnover Ratio

Shenzhen Stock Exchange: 300357.SZ

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

CEO	Mr. Gengxi Hu Ph.D.
IPO Date	Jan. 21, 2014
Location	China
Headquarters	No. 636, Zhiyuan North Road
Employees	1,709
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, researches, develops, produces, and sells pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. It also offers skin care and stem cells series. The company is headquartered in Huzhou, China.

Key trends

Past 5 years